Compartir
Percutaneous Interventions for Structural Heart Disease: An Illustrated Guide (en Inglés)
Reimers, Bernhard ; Moussa, Issam ; Pacchioni, Andrea (Autor)
·
Springer
· Tapa Blanda
Percutaneous Interventions for Structural Heart Disease: An Illustrated Guide (en Inglés) - Reimers, Bernhard ; Moussa, Issam ; Pacchioni, Andrea
$ 267.850
$ 446.410
Ahorras: $ 178.560
Elige la lista en la que quieres agregar tu producto o crea una nueva lista
✓ Producto agregado correctamente a la lista de deseos.
Ir a Mis Listas
Origen: Reino Unido
(Costos de importación incluídos en el precio)
Se enviará desde nuestra bodega entre el
Jueves 11 de Julio y el
Viernes 19 de Julio.
Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.
Reseña del libro "Percutaneous Interventions for Structural Heart Disease: An Illustrated Guide (en Inglés)"
This book presents the percutaneous techniques and technologies most frequently employed in structural interventional cardiology, focusing especially on how to optimize outcomes and minimize risk. Interventional procedures for aortic stenosis, mitral regurgitation, left atrial appendage closure, patent foramen ovale closure, and closure of interatrial and interventricular defects are clearly presented step by step with the aid of a wealth of images. These descriptions are complemented by a case-based analysis of the various structural pathologies and their complications. Clear guidance is also provided on patient selection, preoperative evaluation, and choice of available devices. The authors are all acknowledged experts with extensive experience in laboratories and surgical units. The book fully reflects the rapid changes in structural interventional cardiology that have occurred during recent years. These advances are in particular due to the introduction of transcatheter aortic valve implantation, which allows cardiac surgeons to achieve excellent outcomes in patients at high surgical risk. Other exciting developments include new technologies that permit better treatment of other structural cardiac pathologies and valid alternatives to medical therapy in particular patient groups."
